Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Tax Reform Could Lead to Spike in Biopharma M&A Activity

2h biospace
The passing of tax reform led most analysts to predict that 2018 will be a strong year for mergers and acquisitions. Data and analytics firm GlobalData followed suit. Rahael Maladwala, a healthcare analyst with the company, said in a recent report, “The tax reform includes a huge cut in the overall tax rate, down to less than 20 percent for most companies, leaving large pharmaceutical giants with an influx of excess cash. (32-0)

BRIEF-Pfizer Receives Positive CHMP Opinion For Two Hematology Medicines

2018-02-23 reuters
* PFIZER INC - CHMP OF EMA HAS ADOPTED POSITIVE OPINIONS RECOMMENDING THAT MYLOTARG, BOSULIF BE GRANTED MARKETING AUTHORIZATIONS IN EU Source text for Eikon: Further company coverage: (16-0)

BRIEF-Albert Bourla Elected To Pfizer’S Board Of Directors

2018-02-23 reuters
* PFIZER INC - ‍BOURLA IS CURRENTLY COO OF PFIZER​ Source text for Eikon: Further company coverage: (16-0)

Pfizer (PFE) a Hold at $35.77

2018-02-22 investorplace
This week, Pfizer (PFE) stays a Hold based on the most recent relative pricing of its shares and analysis. The reasoning behind Pfizer Inc's (NYSE:PFE) current Hold recommendation is an analytical score that is near average, a ranking in the company's sector group that is in the middle third, a ranking in its industry group that is in the middle third-below average, and a numerical calculation of risk/reward that is average. (16-0)

Jeremy Corbyn Has a Point About Bankers - Bloomberg

2018-02-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (52-0)

Stock Market News For Feb 20, 2018

2018-02-20 zacks
Markets closed mostly higher on Friday. While the Dow and the S&P 500 eked out gains to post their sixth straight session of gains, the Nasdaq slumped and ended in the negative territory. However, all three major benchmarks posted their biggest weekly closes. (33-0)

Pfizer Limited - Change in Director(s)

2018-02-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (16-0)

Pfizer, UnitedHealth Boost DJIA on Friday

2018-02-17 247wallst
February 16, 2018: Markets opened mixed Friday but set a course for solid gains following the report the consumer sentiment had reached its second-highest level in 14 years. Consumers were not fazed by the equity sell-off earlier this month, but far more stoked by the tax cuts. (40-0)

IntelliPharmaCeutics International's (IPCI) CEO Isa Odidi on Q4 2017 Results - Earnings Call Transcript

2018-02-16 seekingalpha
Greetings, and welcome to Intellipharmaceutics' 2017 Year-End Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] (37-1)

BioXcel Therapeutics Seeks $69 Million U.S. IPO

2018-02-16 seekingalpha
The firm is using the advanced data and AI technologies of its parent company to improve its drug development efforts. (381-3)

Bristol-Myers Squibb (BMY) in Focus: Stock Moves 5.6% Higher

2018-02-16 zacks
Bristol-Myers Squibb Company (BMY - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $60.90 to $64.43 in the past one month time frame. (21-0)

5 Low Leverage Stocks You Will Love on Valentine’s Day

2018-02-15 investorplace
Indeed, in the complex world of investment, understanding the amount of financial leverage a company bears is crucial. Per the theory of cost of capital, a company’s capital structure reflects a mix of debt and equity that is used to finance its capital projects. Now a comparative analysis of the same theory reveals that most companies prefer debt financing over equity since debt is cheaper, especially in periods of low interest rates. (21-0)

3 Reasons to Be Bullish on Pfizer Inc. Stock

2018-02-14 investorplace
Just a few weeks ago, Pfizer Inc. (NYSE:PFE) shares hit a 52-week high of $39.43. But of course, the recent correction in the equities markets has left a mark. During the period, PFE stock has lost about 11%. (29-0)

Merck Will End Alzheimer's Trial as Alternative Approach Fails - Bloomberg

2018-02-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (16-0)

Merck scraps another late-stage Alzheimer's drug study - Channel NewsAsia

2018-02-13 channelnewsasia
NEW YORK: Merck & Co Inc on Tuesday said it will end another late-stage trial of an Alzheimer's drug because it was unlikely to work, adding to the pile-up of failures to find an effective treatment for the mind-wasting disease. (16-0)